THE Pharmaceutical Society of Australia is seeking submissions on its revised Compounding Standard, yesterday releasing a consultation paper which is open to feedback until 18 Apr 2017.
The consultation is part of a wider review of PSA's Professional Practice Standards, and outlines the requirements for pharmacists to enable patients to have timely access to safe, efficacious and quality compounded medicines.
A key outcome of the review has been to ensure consistency of the PSA standard with the Pharmacy Board of Australia's Guidelines on compounding of medicines, in particular relating to the difference between simple and complex compounding activities.
The PSA Standard is intended to apply to all compounding, but also identifies additional actions that need to be undertaken when compounding complex preparations.
It details twelve criteria, under the following headings:
* patient-centred care
* quality assurance
* policy and procedures
* training and education
* risk management & evaluation
* documentation
* facilities and equipment
* storage, stability and disposal
* dispensing and other supply arrangements
* compounding practice
* counselling and
* monitoring, review & follow-up.
The review also highlighted the requirement for compounding activities to be guided by appropriate risk assessments.
The project was funded as part of the government's PBS Access and Sustainability Package which includes the Sixth Community Pharmacy Agreement.
The consultation paper and a survey are online at psa.org.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 22 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Mar 17
